REGN vs TTI
Regeneron Pharmaceuticals Inc (REGN) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
TTI does not have a complete income-statement cache yet.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the REGN and TTI stock pages for the full models.
Not investment advice.